Medicare Bundled Payments and COPD ReadmissionsMay 5, 2017 at 4:09 pm
By David Lederer, MD, MS, editor, Annals of the American Thoracic Society
Follow Dr. Lederer on Twitter @AnnalsATSEditor
In their May Annals of the American Thoracic Society article, Surya P. Bhatt and colleagues at the University of Alabama at Birmingham and the Birmingham VA Medical Center report on a study of whether the Centers for Medicare & Medicaid Services Bundled Payments for Care Improvement (BPCI) program reduced 30- and 90-day all cause readmission rates for COPD exacerbations, as well as overall costs. Seventy-eight Medicare patients were enrolled in the intervention in 2014, compared with 109 patients from 2012 who did not receive the intervention. Despite higher rates of influenza and pneumococcal vaccinations, referrals to pulmonary rehabilitation, and follow-up pulmonary appointment, BPCI patients did not have lower 30- or 90-day all cause readmission rates, nor was the cost of their care lower.